Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00632476 · ClinicalTrials.gov registry record · NA

Evaluating the Effects of Supplemental Vitamin C on Infant Lung Function in Pregnant Smoking Women

A NA study of Pregnancy and Smoking, sponsored by Oregon Health and Science University.

Completed
Registry status
NA
Development phase
282
Enrollment target
1
Study location

NCT00632476 is a NA study of Pregnancy and Smoking that has completed, run by Oregon Health and Science University. The registered enrollment target is 282 participants, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00632476, a NA study of Pregnancy and Smoking, has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
NA
Development phase
282 participants
Enrollment target
1
Study location

Study Summary

Women who smoke during their pregnancy place their unborn child at an increased risk of health problems, including decreased lung function and possible lung diseases later in life. Preliminary animal research suggests that if vitamin C is taken during pregnancy, nicotine's harmful effects on the unborn baby's developing lungs may be blocked. This study will determine the effect that vitamin C has on the lung development and function of babies born to women who smoke during pregnancy.

Conditions Studied

Interventions

  • OTHER Placebo
  • DIETARY_SUPPLEMENT Vitamin C

Study Locations (1)

Oregon

  • Oregon Health & Science University - Portland

Trial Details

FieldValue
Enrollment Target 282 participants
Start Date 2007-03
Est. Completion 2012-07
Phase NA

What the Registry Record Tells You About NCT00632476

The ClinicalTrials.gov registry entry for NCT00632476 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 282 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (68% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00632476 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT00632476 about?

NCT00632476 is a clinical study titled "Evaluating the Effects of Supplemental Vitamin C on Infant Lung Function in Pregnant Smoking Women". Women who smoke during their pregnancy place their unborn child at an increased risk of health problems, including decreased lung function and possible lung diseases later in life. Preliminary animal research suggests that if vitamin C is taken during pregnancy, nicotine's harmful effects on the unb...

What is the current status of trial NCT00632476?

This trial is currently completed. It is a NA study. The enrollment target is 282 participants. The study started on 2007-03. Estimated completion is 2012-07.

What conditions does trial NCT00632476 study?

This clinical trial studies the following conditions: Pregnancy, Smoking.

What interventions are being tested in trial NCT00632476?

The interventions under investigation include: Placebo (OTHER), Vitamin C (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00632476?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00632476 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.